Clinical Trial Update: An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR [Phase 3]

View source ↗

Summary

An open-label, randomized, cross-over Phase 3 trial comparing mexiletine prolonged-release (PR) vs immediate-release (IR) formulations to evaluate efficacy and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonia

Drugs mentioned

• Mexitil IR (mexiletine)
• Mexitil PR (mexiletine)

Snippet

Sponsor: Lupin Ltd. | Conditions: Myotonia | Phase 3 | Status: RECRUITING